poly-L-lysine-coated microscope slides and were air dried overnight in an oven at 37°C. Dewaxing in xylene and rehydration through a descending series of alcohols was followed by blocking endogenous peroxidase activity with 10% hydrogen peroxide in phosphate buffered saline (PBS) (pH 7A4) for 15 minutes. After washing the sections in running tap water for 5 minutes they were rinsed in PBS plus 1% Tween 80. The PBS was decanted from the sections and any excess fluid wiped off before incubating in mouse anti-pS2 monoclonal antibody at a dilution of 1 in 400 for 2 hours. The washing and decanting procedure was repeated and the sections were incubated in biotinylated rabbit anti-mouse immunoglobulin (Dako) for 45 minutes at a dilution of 1 in 200. After the washing procedure, the tissues were incubated in preprepared streptavidin-biotinylated complex and horseradish peroxidase for 30 minutes and washed again. The peroxidase activity was detected using 1% diaminobenzidine (free base) dissolved in dimethyl formamide plus 100 tl of 30 volumes hydrogen peroxide per 100 ml for 10 minutes. The sections were then washed in running tap water for 5 minutes, counterstained lightly with Mayer's haematoxylin for 30 seconds, blued in tap water, dehydrated in graded alcohols, cleared in xylene and mounted in Depex. Negative control slides were prepared from samples known to be pS2 positive by exclusion of the primary antibody. and the patient's lymph node statu in The surgical samples provided a large cross-section for assessment. The pS2 protein staining was confined to the cytoplasm of the breast cancer cells, with the infiltrating tumour staining principally (fig 1) . The stain-:AAt ing was granular in appearance and sometimes varied in intensity. The luminal contents of the breast ducts stained strongly and occasionally benign and normal elements of the tissue were also positive. The stroma did not stain and there was negligible background staining. In ER fmol/mg protein In PgR fmol/mg protein and ln(PgR) (fig 4) , but to a less significant degree. Subdivision according to menstrual status showed a highly significant correlation between ln(pS2) and ln(ER) (table 2 and fig  3) in tumours from women of 50 or under but not over 50 years. This was not mirrored in the PgR results which were subdivided in a similar manner. Fisher exact probabilities were calculated from the frequencies of ER or PgR positive or negative tumours with regard to their pS2 status by IRMA. ER and PgR positivity was significantly associated in the whole group. There were two tumours which were ER negative and PgR positive; these had borderline PgR values of 15 and 16 fmol/mg protein.
PgR positivity was significantly associated with pS2 positivity but ER positivity was only associated with pS2 positivity in the younger group of patients. In women aged 50 years or younger, there was 100% concordance between pS2 positivity and those tumours which were ER positive and PgR positive whereas three of nine of the ER negative tumours and three of seven PgR negative tumours were pS2 positive. When considering the three proteins in combination, there was an association between ER+ PgR+ pS2 + and ER -PgR -pS2 -phenotypes (MannWhitney probability = 0 03; table 3).
Discussion
The growth of many breast cancers is dependent on oestrogens. Oestrogen is known to up-regulate the expression of PgR"1 and the product of the pS2 gene.20 The pS2 gene was discovered during a search for oestrogen regulated genes in the MCF-7 cell line derived from human breast cancer.2122 The expression population. In Foekens' study,'5 the cut-off 11 ng/mg protein was chosen by isotonic regression analysis as the most powerful predictor of early recurrence and death (in their population) and 27% pS2+ tumours resulted. In our study, the use of 11 ng/mg cut-off also resulted in 28% pS2 + tumours. This is despite the fact that the kit manufacturer's (CIS) standard is different from Foekens': 11 ng of the Foekens' standard is said to be equivalent to 30 ng CIS pS2 protein. We cannot explain this discrepancy but suggest that further work should be conducted to assess the comparability of the standards.
The secondary aim of this work was to provide further data on the relationship between pS2 and ER and PgR. The numbers studied cannot provide a comprehensive statement of the relationship but we were surprised to find that five tumours were ER -pS2 + which was 16% of the total sample (table 3) . Based on the hypothesis that pS2 is an oestrogen regulated gene this anomaly is unexpected, but has been observed before. This is a higher frequency than recorded by Foekens'5 
